DIetary REstriction as an Adjunct to Neoadjuvant ChemoTherapy for HER2 Negative Breast Cancer

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Fasting Mimicking DietBreast CancerNeoadjuvant ChemotherapyPathological Complete Response
Interventions
OTHER

Fasting mimicking diet

Trial Locations (15)

2333ZA

Leids Universitair Medisch Centrum, Leiden

Unknown

Medisch Centrum Alkmaar, Alkmaar

OLVG, Amsterdam

Alexander Monro hospital, Bilthoven

Amphia Hospital, Breda

Deventer Hospital, Deventer

Ziekenhuis Gelderse Valei, Ede

, Catharina ziekenhuis Hospital, Eindhoven

Kennemer gasthuis, Haarlem

Medisch Centrum Leeuwarden, Leeuwarden

Bronovo Hospital, The Hague

Haga Hospital, The Hague

VieCurie Hospital, Venlo

Lange Land Hospital, Zoetermeer

Isala, Zwolle

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Borstkanker Onderzoek Groep

NETWORK

collaborator

Pink Ribbon Inc.

INDUSTRY

collaborator

Amgen

INDUSTRY

lead

Leiden University Medical Center

OTHER

NCT02126449 - DIetary REstriction as an Adjunct to Neoadjuvant ChemoTherapy for HER2 Negative Breast Cancer | Biotech Hunter | Biotech Hunter